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Introduction     The  result  of  treatment  of  infections  involving 
antibiotic-resistant organisms in total knee arthroplasty (TKA) is 
often poor. We evaluated the efficacy of 2-stage revision in TKAs 
infected with resistant organisms and compared the clinical out-
comes with articulating and conventional static spacers, in terms 
of both infection control and function.
Methods   In a prospective manner, from June 2003 to January 
2007 selected patients with a TKA infected with resistant organ-
isms were enrolled and treated with 2-stage re-implantation. The 
45 patients were divided into 2 groups: group A (23 patients) 
implanted with the articulating spacers and group S (22 patients) 
implanted with static spacers. All patients followed the same anti-
biotic protocols and had the same re-implantation criteria. The 
efficacy of infection control was evaluated using re-implantation 
rate, recurrence rate, and overall success rate. The functional and 
radiographic results were interpreted with the Hospital of Special 
Surgery (HSS) knee score and the Insall-Salvati ratio.
Results   With mean 40 (24–61) months of follow-up, 22 of 
23 knees were re-implanted in group A and 21 of 22 were re-
implanted in group S. Of these re-implanted prostheses, 1 re-
infection occurred in group A and 2 occurred in group S. Range of 
motion after re-implantation, the final functional scores, and the 
satisfaction rate were better in group A. One third of the patients 
in group S, and none in group A, had a patella baja.
Interpretation   After 2-stage re-implantation of TKAs origi-
nally  infected  with  resistant  organisms,  the  clinical  outcome 
was satisfactory—and similar to that reported after treatment 
of TKAs infected with low-virulence strains. Treatment with an 
articulating  spacer  resulted  in  better  functional  outcome  and 
lower incidence of patella baja.
 
Two-stage  re-implantation  has  been  reported  to  give  better 
infection control than 1-stage revision surgery (Goldman et al. 
1996) and it is widely used for chronic total knee arthroplasty 
(TKA)  infection.  During  the  interim  period  between  resec-
tion  arthroplasty  and  re-implantation,  antibiotic-laden  bone 
cement spacer is used. The static spacers are usually fashioned 
as a block and keep the knee in extension, which may lead 
to contraction of the extensor mechanism and joint capsule, 
making the subsequent exposure for re-implantation difficult. 
The range of motion and functional outcome after 2-stage revi-
sion is poorer than that after aseptic revision of TKA (Jacobs 
et al. 1989, Wang et al. 2004). With a smooth and congruent 
interface, articulating spacers are designed to allow motion to 
prevent soft tissue contracture and improve the daily activity of 
patients in the hope of better final function.
Many studies have compared the infection control and final 
function  between  treatment  with  articulating  spacers  and 
static spacers (Marsi et al. 1997, Fehring et al. 2000, Emerson 
et al. 2002, Jacobs et al. 2009, Jämsen et al, 2009). However, 
patients in most of these studies were not stratified according 
to infecting organisms and antibiotic treatment. The results of 
clinical studies comparing infections with antibiotic-resistant 
organisms and low-virulence organisms that were treated with 
2-stage  surgery  have  varied  widely  (Hirakawa  et  al.  1998, 
Kilgus et al. 2002, Volin et al. 2004, Mittal et al. 2007). The 
increasing prevalence of resistant organisms makes it impor-
tant to evaluate the clinical efficacy of current treatment meth-
ods in patients who are infected with these organisms.
We have previously reported an easy technique for making 
articulating spacers during surgery, with low cost and good 
quality (Su et al. 2009). In that study, we noted satisfactory 
results for infections with antibiotic-resistant organisms. In 
this prospective controlled study, we evaluated the efficacy 
of  2-stage  revision  for TKA  infected  with  resistant  organ-
isms—methicillin-resistant  Staphylococcus  aureus  (MRSA) 
and methicillin-resistant coagulase-negative Staphylococcus 
(MRCNS)—and compared the clinical outcomes from using 
articulating  spacers  or  conventional  static  spacers  together 
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Methods
We included patients who had type-II (late chronic) total knee 
infection with documented antibiotic-resistant Staphylococ-
cus strains: MRSA or MRCNS. The patients met at least one 
of the following criteria of deep infection: infective loosen-
ing, drainage sinus, or recurrent infection after debridement. 
Patients who suffered from neuromuscular disease precluding 
active motion, who had had previously failed septic revision 
TKA, who had major bone defects, who had complete tear of 
collateral ligament, or who had knee motion of less than 45 
degrees were excluded. From June 2004 to January 2007, in 
a prospective manner, 46 selected patients were split into 2 
groups by selecting every other patient. The process of des-
ignation was open to the medical team only. In group A, 23 
patients were implanted with in-house articulating spacers and 
in group S, 23 patients had block-type static spacers. 1 patient 
in group S moved away before re-implantation and was lost to 
follow-up (Figure 1 and Table 1). 6 patients in group A were 
also reported in the pilot study describing the technique of 
making articulating spacers used in this study (Su et al. 2009).
During  the  resection  surgery,  all  the  old  components, 
cement, and infective tissue were removed. The sclerotic or 
cystic bony surface was refreshed with burrs. Then the wound 
and  medullar  canal  were  irrigated  thoroughly  with  pulse 
lavage. Simplex-P cement (Howmedica, Rutherford, NJ) was 
used to make spacers. 
In the group with articulating spacers, 2 g of vancomycin 
was hand-mixed with each 40-g package of cement. In total, 
6 g of vancomycin in 3 packs of cement was used for each 
case. The articulating spacers were cast intraoperatively with 
molds fabricated from silicon rubber, polydimethyl siloxane 
(Coltoflax;  Coltène AG, Altstatten,  Switzerland)  according 
erly restored and care was taken not to balance the gap tension 
too tight (Figure 2).
In the group with static spacers, 6 g of vancomycin was 
mixed with 2 packs of cement. Each 40-g package of cement 
contained 3 grams of vancomycin. The cement was fashioned 
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Figure 1. Flow diagram of enrollment.
Table 1. Demographic data
    Articulating spacer  Static spacer
    (n = 23)  (n = 22)
Age (years)  71 (65–78)  72 (67–80)
Sex (female / male)  13 / 10  10 / 12
Infected TKA  19  18
Infected revised TKA    4    4
After debridement  13    9
Medical co-morbidities    9  11
  Diabetes mellitus    6    7
  PAOD    1    1
  End-stage renal disease    2    1
  Rheumatoid arthritis    1    2
  Others    1 breast cancer    1 liver cirrhosis, 
           Child A
Bacteriology   
  MRSA  19  20
  MRCNS    4    2
Intravenous antibiotics (weeks)  3.4 (2.5–4.5)  3.1 (2.5–4.5)
Oral antibiotics (weeks)  8.3 (4–11)  8.1 (4–10)
Spacer stage (months)  3.4 (2.5–5)  3.1 (2–4)
Re-implantation  22  21
Surgical approach   
  Medial parapatellar  22  14
  Quadriceps snip    0    6
  V-Y plasty    0    1
Mean follow-up (months)  41 (24–61)  40 (24–59)
PAOD: peripheral arterial occlusion disease; 
MRSA: methicillin-resistant Staphylococcus aureus; 
MRCNS: methicillin-resistant coagulase-negative staphylococci.
to the technique already described (Su et 
al. 2009). Briefly, the doughy putty matrix 
of  polydimethyl  siloxane  is  thoroughly 
mixed with the catalyst (alkyl silicate) and 
applied to the surface of a prosthesis col-
lected before surgery for use as a template. 
It will set in 5 to 10 min. The negative 
impression made from this material repli-
cates the smooth surface of the prosthesis 
in detail. To make each set of knee spac-
ers,  separate  molds  for  the  femoral  and 
insert parts are required. These molds can 
be  re-used  and  re-sterilized  with  perox-
ide plasma. After prosthesis removal, and 
meticulous debridement and irrigation, the 
first pack of cement was poured into the 
prefabricated  molds  to  cast  the  femoral 
and insert parts of the spacers. The other 
2 packs of cement were used sequentially 
to fix the spacers. All spacers were loosely 
fixed to the bone. The joint line was prop-462  Acta Orthopaedica 2011; 82 (4): 460–464
into a block, which was fitted into extension gap with the knee 
straight.
After surgery, on limbs with static spacers, long leg splint-
ing  was  applied  followed  by  casting  until  re-implantation. 
Patients with the articulating spacers had a long leg splint 
for 1 week and they were then encouraged to perform range-
of-motion exercises as tolerated, and to walk with protective 
weight bearing. Continuous passive motion was used during 
hospitalization.
All patients followed a similar antibiotics protocol after sur-
gery. Intravenous antibiotics, vancomycin or teicoplanin, were 
given for at least 2 weeks or until clinical infection control was 
observed and CRP had decreased to less than 2.0 mg/dL. Oral 
sodium fusidate tablets were prescribed on an outpatient basis 
for at least 4 weeks or more, until the CRP value returned to 
normal. The criterion for re-implantation was CRP of < 1.0 
mg/dL two weeks after discontinuing the oral antibiotics, and 
without any clinical signs of infection. 
Re-implantation  was  done  using  a  medial  parapatellar 
approach. Quadriceps snip or V-Y lengthening was used only 
when adequate exposure could not be obtained otherwise. The 
spacers were removed and soft tissue between the cement and 
bone junction was sent for frozen sectioning (considered posi-
tive for infection with ≥ 10 polymorphonuclear leukocytes per 
high-power field). The revision prostheses used were all of the 
non-hinged type (LCCK; Zimmer, Warsaw, IN). Vancomycin-
impregnated cement was used to fix the prosthesis with 1 g 
antibiotic per 40-gram package of cement. The management 
after re-implantation was similar to that for aseptic revision 
surgery  except  that  there  were  6  additional  weeks  of  oral 
sodium fusidate.
The  change  in  patella  tendon  length  was  measured  by 
comparing the Insall-Salvati ratio (Insall and Salvati 1971) 
between stages. Patella baja was defined as a ratio of less than 
0.8. Knee function was evaluated with the Hospital of Spe-
cial Surgery (HSS) knee score (Insall et al. 1976). Evaluations 
were performed by an independent investigator.
Statistics 
Continuous variables such as change in Insall-Salvati ratio 
before and after each type of treatment and the functional 
scores were analyzed with a Student t-test. The association 
between  type  of  treatment  and  each  categorical  variable 
(infection control, re-infection, and presence of patella baja) 
was analyzed with Fisher’s exact test. Differences were con-
sidered to be statistically significant at p-values of < 0.05.
Results
The  distribution  of  sex,  age,  and  clinical  background  was 
similar between the groups. Group A had 19 cases of MRSA 
and 4 cases of MRCNS infection while group S had 20 cases 
of MRSA and 2 cases of MRCNS infection. These resistant 
strains were all sensitive to vancomycin. 
The  intravenous  vancomycin  was  administrated  through-
out the entire hospitalization period after resection surgery, 
which was about 3 weeks on average for both groups. Oral 
antibiotics were used for mean 8 weeks in both groups. All the 
patients tolerated the antibiotics well. 
The  average  interval  between  resection  arthroplasty  and 
re-implantation was 3.4 months in group A and 3.1 months 
in group S. During the spacer stage, the patients in group A 
achieved mean 83 degrees of knee flexion (maximum 105 
degrees).  They  could  sit  comfortably  with  bent  knees  and 
walk with partial weight bearing. Crepitating sound from the 
knee was felt by all patients, and various degrees of cogwheel 
motion were also noted, especially in the first few weeks. 
However, the phenomenon disappeared within a month. Only 
1 patient experienced knee lock at flexion during hospitaliza-
tion, which resolved after skin traction. No gross instability of 
the knee was noted. 
All but 2 patients (1 in each group) were re-implanted. The 
failed patient in group A had a fluctuating CRP level, and 
the infection recurred with a discharging wound during the 
period without drugs. He had another debridement to retrieve 
the residual cement in the femoral canal, and was implanted 
with a new articulating spacer. Re-implantation was done suc-
cessfully after 3 months. The failed patient in group S had a 
persistent discharging sinus and was treated with arthrodesis.
Figure 2. Spacers cast with PDMS molds provide a smooth interface. 
Care  should  be  taken  to  balance  the  gap  tension  and  restore  the 
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All of the revision surgeries in group A (22 patients) were 
carried through medial parapatellar arthrotomy, while 7 of 21 
patients in group S required extensor interruption to obtain 
adequate exposure. The average surgical time was 121 min in 
group A and 163 min in group S. Frozen sections and bacterial 
cultures were all negative at re-implantation.
The functional results at mean 40 (24–61) months of follow-
up were better in group A in terms of HSS knee score and 
knee motion (Table 2). There was no substantial extension lag 
in group A, while those who had extensor interruption pro-
cedures in group S had various degrees of extensor lag. The 
Insall-Salvati ratio in group A was similar before and after 
2-stage revision. However, in group S, it decreased from 0.95 
to 0.81 after revision and one third of the patients had a patella 
baja, as compared to none before resection. The satisfaction 
rate for the mobile spacer was statistically significantly higher 
in group A. In group S, inconvenience from a straight stiff 
knee was the commonest complaint followed by problems 
from the cast, such as pressure sores and dermatitis.
The number of re-infections at the latest follow-up was 1 in 
group A and 2 in group S. The one patient in group A had had 
an infected revision TKA before the 2-stage treatment while 
the 2 patients in group S had an infected primary and revision 
TKA, respectively. All 3 cases fulfilled the re-implantation 
criteria and their frozen sections during the index surgery were 
negative for active infection. Only 1 of them (in the S group) 
had the same pathogen. The other 2 failures had negative cul-
tures but had obvious clinical presentation (one with a dis-
charging wound, the other with an erythmatous swelling along 
with an elevated white count in the joint aspiration).
Discussion
With numerous different protocols and various types of bac-
teria reported, the success rate of 2-stage total knee revision 
varies between from 82% and 100% (Rosenberg et al. 1988, 
Windsor et al. 1990, Goldman et al. 1996, Jacobs et al. 2009, 
Jämsen et al. 2009). The prognosis for arthroplasties infected 
with resistant organisms has been reported to be poor. In a 
retrospective study of infected arthroplasties in 70 patients 
(Kilgus et al. 2002), the success rates by surgical treatment 
were only 9/19 for hip replacements and 3/16 for knee replace-
ments infected with MRSA or methicillin-resistant Staphylo-
coccus epidermidis (MRSE). Hirakawa et al. (1998) reported 
a success rate of 12/18 after two-stage revision for total knee 
arthroplasty infected with resistant organisms, while it was 
20/24 for those infected with low-virulence organisms. How-
ever, some authors have reported better results. In a compara-
tive study involving 46 patients, Volin et al. (2004) found 1 
failure out of 9 after 2-stage re-implantation for total joints 
infected with methicillin-resistant organisms, as compared to 
2 out of 37 for methicillin-sensitive organisms. In a multicenter 
study involving 37 patients who had a total knee arthroplasty 
infected with resistant organisms and who underwent 2-stage 
reimplantation, Mittal et al. (2007) reported eradication of the 
infection in 33 patients, when those who were re-infected with 
an organism different from the original one were included. In 
our study, 40 of the 45 patients became infection-free after 
re-implantation, which supports the efficacy of 2-stage reim-
plantation for TKAs infected with resistant organisms.
The  potential  advantages  of  articulating  spacers  are  a 
facilitated re-implantation and better final functional results. 
However, it is still unclear whether the efficacy of infection 
control is comparable between articulating and static spacers. 
In many series using articulating spacers with case numbers 
exceeding 20, the re-infection rate has ranged between 0% and 
12% (Hofmann et al. 1995, 2005, Haddad et al. 2000, Emer-
son et al. 2002, Durbhakula et al. 2004, Evans 2004, Meek et 
al. 2004), which is similar to the results in series with static 
spacers (Jacobs et al. 1989, Windsor et al. 1990, Goldman 
et al. 1996, Fehring et al. 2000, Emerson et al. 2002, Wang 
et al. 2004). Fehring et al. (2000) and Emerson et al. (2002) 
reported similar infection recurrence rates for use of articulat-
ing and static spacers in their comparative studies. Jacobs et 
al (2009) reviewed 18 studies on infected prostheses treated 
with two-stage re-implantation, and found re-infection rates 
(after pooling of cases) of 6% (21/361) for mobile spacers and 
8% (10/122) for static spacers. However, to our knowledge 
there have been few prospective studies comparing these two 
different approaches, solely based on resistant organisms. In 
our series, the success rates were similar for articulating and 
static spacers.
Failure to provide an anatomic surface in articulating spac-
ers  may  cause  instability. The  impression-taking  technique 
described in this study used polydimethyl siloxane (PDMS) 
and  Coltoflax  to  make  molds.  PDMS  is  a  non-toxic,  bio-
compatible material that is commonly used in the process of 
microfabrication for tissue engineering. It is also widely used 
in dental procedures with its property of easy handling. The 
molds have a smooth surface that exactly reflects the shape of 
Table 2. Clinical results
  Articulating spacer  Static spacer
  (n = 23)  (n = 22)
Re-infection rate      1/22    2/21
Success rate    21/23  19/22
ROM at spacer stage (°)    84 (50–105)    0
Post-revision ROM (°)  113 (95–125)  85 (70–100) b
Post-revision HSS score    90 (86–94)  82 (81–88) b
Patella baja   
   Preoperative (%)    0    0
      Mean ISR a     0.98    0.95
   Postoperative (%)    0  33 b
      Mean ISR a    0.93    0.81 b
Satisfaction rate    21/23    7/22 b
a Insall-Salvati ratio.
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the original prosthesis. It does not adhere to the cement, so the 
use of any lubricant is avoided. With these spacers, we found 
no  gross  instability  or  spacer  breakage. All  patients  could 
walk with partial weight bearing and sit comfortably with bent 
knees. Thus, higher satisfaction rate was observed in patients 
with better joint ROM.
Although antibiotic-laden bone cement has been used for 
many decades, there is no consensus about the amount of 
antibiotics that should be mixed into the cement spacers. We 
mixed 2 g of antibiotics with 40 g of cement, and each knee 
contained 6 g of antibiotics in total. This dosage is at the lower 
range of the usual recommended dose (Hanssen and Spangehl 
2004, Jiranek et al. 2006). We did, however, achieve a good 
rate of eradication of infection with this dosage.
Two-stage revision with static spacers has been reported 
to be frequently associated with complications due to poor 
bone quality, patella tendon avulsion, extension lag, flexion 
limitation, and extension instability (Rosenberg et al. 1988, 
Windsor et al. 1990, Goldman et al. 1996, Meek et al. 2004). 
In our study, none of the patients with articulating spacers 
had  these  complications.  Gap  tensioning  was  done  during 
the spacer surgery, so there was no need for extensive scar 
release during the re-implantation procedure, which resulted 
in shorter operation time. On the other hand, patients with 
static spacers required more extensor mechanism interruption, 
which may result in extension lag; one third of patients with 
static spacers developed patella baja after a long-term casting. 
Not surprisingly, the patients treated with articulating spacers 
achieved much better functional results than those who were 
treated with static spacers.
In  summary,  2-stage  re-implantation  with  articulating 
spacers impregnated with vancomycin achieved an infection 
eradication rate similar to that with static spacers for TKAs 
infected with methicillin-resistant Staphylococcus aureus or 
methicillin-resistant coagulase-negative Staphylococcus. The 
use of articulating spacers avoided the development of patella 
baja and complications from the extensor mechanism, which 
led to better functional results.
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